Merck & Co. Inc. buy BMO Capital Markets
Start price
01.11.24
/
50%
€94.50
Target price
01.11.25
€125.35
Performance (%)
-20.95%
End price
02.11.25
€74.70
Summary
This prediction ended on 02.11.25 with a price of €74.70. The prediction for Merck & Co. Inc. disappointed with a performance of -20.95%. BMO_Capital_Markets has a follow-up prediction for Merck & Co. Inc. where he still thinks Merck & Co. Inc. is a Buy. A total of €1.58 was paid as dividends for this prediction. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | 0.199% | 0.199% | 17.799% |
| iShares Core DAX® | -3,64 % | -8,78 % | -0,69 % |
| iShares Nasdaq 100 | -2,99 % | -1,71 % | 11,95 % |
| iShares Nikkei 225® | -3,00 % | -9,10 % | 23,39 % |
| iShares S&P 500 | -2,39 % | -2,78 % | 7,62 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target lowered by analysts at BMO Capital Markets from $150.00 to $136.00. They now have an "outperform" rating on the stock.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Current prediction by BMO_Capital_Markets for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€85.40
18.12.25
18.12.25
€110.75
18.12.26
18.12.26
17.80%
24.03.26
24.03.26
Stopped prediction by BMO_Capital_Markets for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€101.00
27.10.23
27.10.23
€125.02
27.10.24
27.10.24
-4.06%
28.10.24
28.10.24